SCAF11 and hepatocellular carcinoma: Zhang et al. [22] identified a new signature featuring seven PRGs (BAK1, CHMP4B, NOD2, NLRP6, GSDMC, PLCG1, and SCAF11) in predicting the prognosis of hepatocellular carcinoma (HCC) patients.